arrow
L

Laura Giordano

azienda ospedaliera bianchi-melacrino-morelli
H指数:39
被引数:5,552

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Stem Cell Mobilization and Autologous Transplantation Outcomes After First-Line R-DA-EPOCH in High-Risk DLBCL and HGBCL: A Single-Center Retrospective Study

高危DLBCL和HGBCL患者接受一线R-DA-EPOCH治疗后干细胞动员和自体移植结局:一项单中心回顾性研究

Cancers
IF4.4
2026-06-080
OA
Reduced relapse rate and improved GVHD/relapse free survival (GRFS) with pharmacokinetics-guided busulfan conditioning regimen for allogeneic stem cell transplantation in adult patients with myeloid hematologic malignancies

成人髓系血液恶性肿瘤患者异基因干细胞移植中,采用药物动力学指导的博来霉素预处理方案可降低复发率并改善GVHD/复发自由生存(GRFS)

2026-03-010
PRE
Real-World Experience of Efficacy and Tolerability of Continuous Infusion Ifosfamide for Advanced Soft Tissue and Bone Sarcoma Patients: A Single Centre Retrospective Cohort

连续输注异环磷酰胺在晚期软组织和骨肉瘤患者中的疗效和耐受性的真实世界经验:一项单中心回顾性队列研究

2026-02-150
OAAI
Reasons driving choice and clinical course of patients with CNS WHO grade 3 IDH mutant glioma receiving vorasidenib after surgery: a pilot experience

手术后接受vorasidenib的CNS 3级IDH突变型胶质瘤患者的驾驶选择和临床过程的原因: 试点经验

2026-01-280
PRE
Bendamustine in combination with gemcitabine and vinorelbine as salvage regimen for relapsed or refractory peripheral T-cell lymphomas: A retrospective single-centre experience

苯达莫司汀联合吉西他滨和长春瑞滨作为复发或难治性外周T细胞淋巴瘤的挽救方案: 回顾性单中心经验

2026-01-210
PRE
Reduced incidence of relapse after checkpoint inhibitors relative to brentuximab vedotin as salvage therapy before allogeneic stem cell transplantation for refractory/relapsed Hodgkin lymphoma: A retrospective analysis

与作为异基因干细胞移植前难治/复发霍奇金淋巴瘤挽救治疗的 brentuximab vedotin 相比,检查点抑制剂后复发的发生率降低:一项回顾性分析

2025-08-310
OAAI
Cardiac MRI study of adverse events in patients treated with immune checkpoint inhibitors: a prospective cohort study of cardiac adverse events

免疫检查点抑制剂治疗患者中心脏不良事件的MRI研究:一项前瞻性队列研究

2025-03-180
OA
Bendamustine in Combination with Gemcitabine and Vinorelbine As Salvage Regimen for Relapsed or Refractory Peripheral T-Cell Lymphomas: A Retrospective Single Center Experience

bendamustine与gemcitabine和vinorelbine联合应用作为复发或难治性外周T细胞淋巴瘤的挽救治疗方案:一项单中心回顾性研究经验

BLOOD
IF23.1
2024-11-050
PRE
Multicenter phase I/II trial of gemcitabine, oxaliplatin and nab-paclitaxel as first-line treatment for patients with advanced biliary tract cancer

吉西他滨,奥沙利铂和nab-紫杉醇作为晚期胆道癌患者一线治疗的多中心I/II期试验

2024-08-010
PRE
Correlation between pathological complete response (pCR) and survival outcomes in patients with resectable esophageal (EC) or gastroesophageal junction cancer (GEJC): A large, real-world, single-center cohort analysis
2024-06-010
PRE